Skip to content

Q21

by Neurofield, Inc.

510(k) K221959

Q21 is a medical device (FDA Class II; FDA product code GWQ, Full-Montage Standard Electroencephalograph) made by Neurofield, Inc., cleared under FDA 510(k) K221959 on 31 Aug 2023, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK221959 Date31 Aug 2023ClearedStatusActive

Official records

From the FDA record

Received by the FDA
5 Jul 2022
FDA decision
31 Aug 2023 (Substantially Equivalent)
FDA review time
422 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K221959 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
GWQ
Device class
Class II
Regulation
21 CFR Part 882.1400
Advisory committee
Neurology
FDA decision
SESE Substantially Equivalent

Devices cleared under K221959

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K221959
UDI-DISize and differences
Q21 169
Neurofield, Inc.
16900860410000379 —On the market

Similar devices

Other devices filed under FDA product code GWQ (Full-Montage Standard Electroencephalograph).

Other devices from Neurofield, Inc.

  • Genesis 104

    Class II
  • Q21 169

    Class II
  • NeuroField X3000 17

    Not classified
  • Genesis Sleep

    Class II

See all devices from Neurofield, Inc. →